M Health Fairview's goal of achieving the world's best cardiac arrest survival rate was boosted Tuesday by a $10 million grant that will substantially increase its response capacity.
The funding, from the Helmsley Charitable Trust, will expand the heart-lung bypass capacity at the University of Minnesota Medical Center in Minneapolis and a mobile program that extends this technology to surrounding hospitals and communities.
Known as extracorporeal membrane oxygenation, or ECMO, the technology oxygenates blood outside the body and keeps it flowing through patients until doctors can fix the causes of their heart stoppages.
"This approach will soon become a model for the rest of the nation and around the globe," said Walter Panzirer, a trustee for Helmsley, which has funded more than $100 million in rural and emergency medical innovations in Minnesota.
Only 10% of patients survived cardiac arrests that occurred outside of hospitals in Minnesota in 2022, according to the latest data from the national CARES registry. The national rate was 9.3% that year.
The opportunity to increase survival comes with the one in three cardiac arrests caused by arrhythmias, or irregular heartbeats, that can be shocked back into rhythm with defibrillators, said Dr. Demetris Yannopoulos, the director of the U's Center for Resuscitation Medicine and a global expert on ECMO use for cardiac arrest.
The survival rate for these arrests is already much higher at 25% to 40% in Minnesota, but it could increase to 70% if ECMO was used when defibrillators failed to restore stable heartbeats, he predicted.
"No one has ever seen anything like this, but I think it's absolutely doable," he said.